NRx Pharmaceuticals, Inc. (NRXP) Stock Forecast
Data as of Jun 17, 2026Healthcare · Current price $4.03 (-1.35%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jun 30, 2022 | Vernon Bernardino | H.C. Wainwright | $2.00 | -50.3% |
Top Analysts Covering NRXP
NRXP vs Sector & Market
| Metric | NRXP | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.40 |
| Analyst Count | 16 | 8 | 19 |
| Target Upside | -48.5% | +11475.1% | +17.1% |
| P/E Ratio | -3.27 | 3.91 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $64M | $133M | $203M | 3 |
| 2027-12-31 | $479M | $538M | $620M | 1 |
| 2028-12-31 | $1.10B | $1.10B | $1.10B | 2 |
| 2029-12-31 | $1.71B | $1.92B | $2.21B | 1 |
| 2030-12-31 | $1.89B | $2.12B | $2.45B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.96 | $1.12 | $1.35 | 1 |
| 2027-12-31 | $3.37 | $3.93 | $4.71 | 1 |
| 2028-12-31 | $3.18 | $8.42 | $13.66 | 2 |
| 2029-12-31 | $13.20 | $15.41 | $18.48 | 1 |
| 2030-12-31 | $12.94 | $15.11 | $18.11 | 1 |
Frequently Asked Questions
What is the analyst consensus for NRXP?
The consensus among 16 analysts covering NRx Pharmaceuticals, Inc. (NRXP) is Buy with an average price target of $2.00.
What is the highest price target for NRXP?
The highest price target for NRXP is $2.00, set by Vernon Bernardino at H.C. Wainwright on 2022-06-30.
What is the lowest price target for NRXP?
The lowest price target for NRXP is $2.00, set by Vernon Bernardino at H.C. Wainwright on 2022-06-30.
How many analysts cover NRXP?
16 analysts have issued ratings for NRx Pharmaceuticals, Inc. in the past 12 months.
Is NRXP a buy or sell right now?
Based on 16 analyst ratings, NRXP has a consensus rating of Buy (2.00/5) with a -48.5% upside to the consensus target of $2.00.
What are the earnings estimates for NRXP?
Analysts estimate NRXP will report EPS of $1.12 for the period ending 2026-12-31, with revenue estimated at $133M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.